2020

1. A 3-year prospective study of a multidisciplinary early proactive therapeutic drug monitoring programme of infliximab treatments in inflammatory bowel disease

   British Journal of Clinical Pharmacology, Vol. 86, Núm. 6, pp. 1165-1175